Related Experiment Video
Updated: Sep 6, 2025

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.3K
Simulating the progression of brain structural alterations in Parkinson's disease
Chang-Hyun Park1,2, Na-Young Shin3, Sang-Won Yoo4
1Department of Radiology, College of Medicine, Catholic University of Korea, Seoul, Korea.
NPJ Parkinson'S Disease
|June 28, 2022
Summary
Parkinson's disease (PD) progression can be inferred by tracking brain structural changes. White matter disintegrity often precedes gray matter thinning, with these alterations appearing before major symptoms and correlating with severity.
Area of Science:
- Neuroscience
- Radiology
- Neurology
Background:
- Parkinson's disease (PD) involves progressive neurodegeneration affecting brain structure.
- Understanding the sequence of structural alterations is crucial for predicting PD progression.
- Magnetic Resonance Imaging (MRI) offers insights into brain structural changes.
Purpose of the Study:
- To infer the progression of Parkinson's disease (PD) by ordering observed brain structural alterations.
- To correlate the sequence and staging of structural changes with clinical status in PD patients.
Main Methods:
- Cross-sectional MRI scans were used to measure cortical thinning (gray matter) and white matter (WM) disintegrity in 130 PD patients.
- Stochastic simulation, based on probabilistic relationships between brain regions, was employed.
- The study inferred the ordering and staging of structural alterations relative to clinical progression.
Main Results:
- White matter (WM) disintegrity was observed to occur earlier than gray matter (GM) cortical thinning.
- Structural alterations predominantly preceded major clinical complications like postural instability and dementia.
- The inferred sequence of structural alterations significantly correlated with the severity of clinical symptoms.
Conclusions:
- The specific ordering of brain structural alterations provides a potential biomarker for predicting Parkinson's disease progression.
- This sequence-based approach may offer clinical feasibility for staging PD and anticipating disease severity.
- Early detection of WM and GM changes can inform prognosis and management strategies.
Related Concept Videos
Parkinson's Disease: Overview
700
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
700
Neural Regulation
39.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.8K
Parkinson's Disease: Treatment
371
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
371

